4D Molecular Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
4D Molecular Therapeutics, Inc.‘s stocks are currently a part of 81 hedge funds’ portfolios, which represents 77.55% of the total amount of its stocks outstanding. This makes up a total of 25.06M shares of 4D Molecular Therapeutics, Inc.. Compared to the previous quarter, the number fell by -3.81% or -993.41K shares fewer. As for the holding position changes, 33.33% (27) of current hedge fund investors increased the number of shares held, 30.86% (25) of current holders sold a part of the shares held, and 16.05% (13) closed the holdings completely. 12 hedge funds are new holders of 4D Molecular Therapeutics, Inc. stock in Q3 2022, it is 14.81% of total holders.
Hedge funds holding 4D Molecular Therapeutics (Q4 2020 – Q3 2022)
| Q4 2020 | 52 |
|---|---|
| Q1 2021 | 64 |
| Q2 2021 | 56 |
| Q3 2021 | 64 |
| Q4 2021 | 77 |
| Q1 2022 | 79 |
| Q2 2022 | 89 |
| Q3 2022 | 81 |
Hedge funds changes in 4D Molecular Therapeutics positions (Q4 2020 – Q3 2022)
| Q4 2020 | 52 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2021 | 28 | 13 | 13 | 16 | -6 |
| Q2 2021 | 10 | 31 | 11 | 18 | -14 |
| Q3 2021 | 12 | 31 | 11 | 4 | 6 |
| Q4 2021 | 22 | 43 | 7 | 10 | -5 |
| Q1 2022 | 10 | 32 | 27 | 8 | 2 |
| Q2 2022 | 25 | 27 | 22 | 13 | 2 |
| Q3 2022 | 12 | 27 | 25 | 13 | 4 |
Hedge funds changes in 4D Molecular Therapeutics stock options (Q4 2020 – Q3 2022)
| Q4 2020 | 0 | 0 |
|---|---|---|
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 2,000 |
| Q3 2021 | 0 | 2,000 |
| Q4 2021 | 9,000 | 495,000 |
| Q1 2022 | 1,792,000 | 0 |
| Q2 2022 | 1,085,000 | 5,000 |
| Q3 2022 | 760,000 | 0 |